Page 198 - Tata_Chemicals_yearly-reports-2017-18
P. 198

` in crore   254.82    254.82   ` in crore  Non-controlling   interests   2,598.46    240.99    (26.33)   214.66    (178.46)   (10.77)   2,623.89    269.41    11.10    280.51    -      (188.51)   1.27    2,717.16

            &RQVROLGDWHG 6WDWHPHQW RI &KDQJHV LQ (TXLW\ IRU WKH \HDU HQGHG    0DUFK



                                   Total   attributable  Foreign currency   to the equity   translation   shareholders of   reserve  the parent   6,599.50    1,443.28    993.11    -        375.29    56.30    1,368.40    56.30    (306.62)   -      (7.86)   -      7,653.42    1,499.58    2,433.08    -      1,097.70    (42.12)   3,530.78    (42.12)   -      -      (337.31)   -      -      -      10,846.89    1,457.46





                                   Items of other comprehensive income  Effective   portion of cash   flow hedges   (67.95)   1,425.98    -        -        73.55    410.68    73.55    410.68    -      -      -      -      5.60    1,836.66    -      -      13.71    1,009.17    13.71    1,009.17    -      (903.98)   -      -      -      -      19.31    1,941.85   Managing Director and CEO  Executive Director














                                 Other Equity  Equity   Retained   instruments  earnings*  through other   comprehensive   income   996.00    993.11    (165.24)   827.87    (306.62)   (7.86)   1,509.39    2,433.08    116.94    2,550.02    903.98    (337.31)   -      4,626.08   For and on behalf of the Board  Director  Director  Director  Director  Director  Director






                                     General   reserve   1,282.47    240.00   -  -   -        -        -        -        -      -      -      -      1,282.47    240.00    -      -      -        -        -        -        -      -      -      -      -      -      1,282.47    240.00   Bhaskar Bhat  Nasser Munjee  Dr. Y. S. P. Thorat  Vibha Paul Rishi  S. Padmanabhan Padmini Khare Kaicker  R. Mukundan  Zarir Langrana





                                   Reserves and surplus  Debenture   Capital   redemption  redemption   reserve  reserve   0.10   -   -        -        -      -      0.10    -      -        -        -      -      -      0.10   Chief Financial Officer  General Counsel &   Company Secretary

                           Other equity (note 16) and non-controlling interests (note 17)





                                     Securities   premium   reserve   1,258.89   -   -        -        -      -      1,258.89    -      -        -        -      -      -      1,258.89   John Mulhall  Rajiv Chandan



                                     Capital reserve   and other   reserves from   amalgamation   20.73   -   -        -        -      -      20.73    -      -        -        -      -      -      20.73


               Equity share capital (note 15)  Balance as at 31 March, 2018  Balance as at 31 March, 2017  Other comprehensive income (net of tax)  Total comprehensive income for the year  Dividends including tax on dividend  Changes in ownership interests in   Acquisition of non-controlling interests  Balance as at 31 March, 2017   Other comprehensive income (net of tax)  Total comprehensive income  for the year  Transferred to Retained earnings - sale of non-  Divid














               a.  Particulars  b.   Particulars  Balance as at 1 April, 2016   Profit for the year   subsidiaries    Profit for the year   current investment  subsidiaries     Additional infusion by NCI    For B S R & Co. LLP  Vijay Mathur  Partner
          196  Annual Report 2017-18
   193   194   195   196   197   198   199   200   201   202   203